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Abstract 
We have designed and evaluated UTX-12 as a novel fluorescent pH probe for tumor hypoxia 
imaging.  UTX-12 consists of a p-nitro benzyl moiety, which is a latent hypoxia-selective leaving 
group activated by nitro reduction, directly linked to SNARF. Although UTX-12 itself is colorless and 
non-fluorescent in aqueous solution, nitro reduction triggers the release of SNARF which has 
well-characterized long wavelength absorption and fluorescence that is sensitive to pH.  The 
resultant SNARF, released intracellularly by enzymatic reduction of UTX-12, allows measurement of 
pH by pH-dependent dual emission shifts.  UTX-12 showed clear differences in fluorescence 
behavior between hypoxic and aerobic conditions in liver microsomes and inside V79 cells.  These 
data are confirmation that UTX-12 is biologically reduced inside tumor cells and the released SNARF 
should monitor intracellular pH of tumor cells selectively with reduced background signal.   
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1. Introduction 
Robust tumor growth requires the presence of 
a local vascular network that supplies both oxygen 
and nutrients to tumor cells. However, a highly 
proliferative mass of tumor cells develops faster than 
the vasculature, and new tumor cells are formed with 
an avascular environment deficient in oxygen, a 
condition known as tumor hypoxia. Tumor hypoxia  
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is characterized by low oxygen tension, low nutrient 
level, low pH and an over-expression of angiogenic 
factors. This is a fundamentally important character 
of the tumor environment because it has been 
associated closely with the malignant phenotype of 
cancer disease, resistance to cancer therapies, and the 
high mortality rate of cancer patients.1 For these 
reasons the specific characteristics of tumor hypoxia 
are attractive targets in the development of anticancer 
drugs.2 In addition, there has been an increasing 
clinical interest in hypoxia-specific molecular probes 
which can characterize the hypoxic cells fraction 
before, during and after therapy.3 
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Figure 1. Presumed reaction schemes of UTX-12 as the fluorescent pH probe activated under hypoxia. 
 
To measure tumor oxygenation in 
experimental or clinical tumors, different analytical 
probes have been used in various methods.4 Among 
these, fluorescent detection has several advantages 
including high resolution, high sensitivity and 
noninvasiveness.3  Included in this approach are a 
few examples of a strategy to identify hypoxic cells 
by using fluorescent probes which become more 
fluorescent after biological reduction resulting from 
tumor hypoxia.5-7  Although these are promising 
candidates as tumor hypoxia-selective fluorescent 
probes, there are two drawbacks.  The first is that 
the maximal absorption wavelength of most of the 
fluorescent probes used in this approach is less than 
500 nm, a complication for bio-imaging because 
there are many biomolecules that absorb at such a 
short wavelength.  In general, fluorophores with 
long absorption and fluorescence wavelengths are 
more suitable as fluorescent probes for in vivo usage.  
The second drawback is that all of these fluorescent 
probes were activated irreversibly under hypoxic 
conditions, a factor that could possibly complicate 
the monitoring of any time-dependent change during 
therapy. The fluorescent probe which has a reversible 
functionality would be more useful because it would 
have the potential to monitor the therapeutic effect in 
real time.8   These considerations prompted us to 
investigate the design of a fluorescent pH probe 
which would be selectively and irreversibly activated 
under tumor hypoxia and subsequently able to 
monitor the pH in its local environment reversibly, 
an important determination since pH measurements 
in tumors have significant diagnostic value. 9 Thus, 
tumor cells have a very high capacity to produce 
lactic acid, which is generated through glucose 
metabolism and inefficient vascular clearing, 
resulting in an acidic microenvironment in solid 
tumors.1 Therefore, the monitoring of tumor pH 
plays a significant role in cancer treatment.10 Here, 
we describe the design and synthesis of new 
fluorescent pH probes to detect tumor hypoxia 
selectively and to monitor the pH of the tumor in a 
reversible manner. 
 
2. Results and Discussion 
 
2.1 Molecular Design 
UTX-12 was designed as the hypoxia-selective 
fluorescent pH probe. This molecule is comprised of 
a p-nitrobenzyl moiety directly linked to SNARF 
(seminaphthorhodafluors) through an ether linkage 
(Figure 1). SNARF belongs to the group of  
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Figure 2. Absorption (black) and emission (red) spectra of 
SNARF derivatives at pH7.0 used in this study. (solid 
line:SNARF, dashed line:UTX-12)  
Table 1. Spectroscopic properties of SNARF and UTX-12. 
Compounds lmaxAbs (e*10-3) a 
(nm)(M-1cm-1) 
lmaxE m 
(nm)b 
 
Φ(*10-2)  
 
e*φ(rel) 
SNARFc 515 (17.7) 
544 (21.6) 
583 3.0 100% 
UTX-12 520 (2.07) 
545 (1.82) 
-d -d <0.5% 
aMeasured in pH5.0 10mM Acetate buffer. bExcited at 534nm.  
c ref. 11. d Precise values cannot be determined because of low 
fluorescence. 
 
asymmetric xanthene derivatives which are well 
known as long-wavelength fluorophores. It is, in 
particular, an example of a pH indicator that shows a 
dual-emission change (typically 583 nm and 627 nm) 
in the neutral pH region (pKa=7.5). It is therefore 
useful for measuring pH changes around the 
physiological pH range (pH 6.5-8.5).11  In our 
strategy, the phenolic substituent of SNARF, which is 
the critical substituent responsible for the unique 
fluorescent properties, was masked by the nitro 
benzyl moiety. This moiety is often used as the 
leaving group activated by biological reduction in 
hypoxia-selective prodrug strategies.2 As depicted in 
Figure 1, the nitro benzyl moiety is reduced via a 
series of one-electron reduction processes to form the 
hydroxylamino (4e-) and amino (6e-) intermediates 
that lead to the release of SNARF. However the 
radical anion product of the first electron reduction 
step is re-oxidized efficiently to UTX-12 in the 
presence of oxygen, making further reduction 
dependent on hypoxic conditions.  This selective 
reduction of the nitro benzyl moiety under hypoxia is 
the key to giving UTX-12 the potential of being a 
hypoxia-selective fluorescent pH probe (Figure 1).   
 
2.2 Spectral Analysis 
We first compared the absorption and the 
fluorescence spectrum of UTX-12 with that of the 
reference compound SNARF (Figure 2).  SNARF 
produced maximal absorption and strong 
fluorescence at 544 nm and 583 nm (lex=534 nm), 
respectively.  In contrast, UTX-12 displayed no 
significant absorption above 400 nm and no 
fluorescence excitation at 534 nm.  The 
corresponding values of lmax, extinction coefficient 
at lmax (e), lem, and quantum yield (f) at pH 5.0 are 
listed in Table 1.  The relative intensities of these 
compounds were determined by calculating the 
product of extinction coefficient and quantum yield 
and then normalizing these values to those of 
SNARF.  These values also are given in Table 1.11  
As compared to SNARF, UTX-12 had less than 0.5% 
of the intensity of SNARF.  It is well known that 
SNARF exists as an equilibrium mixture of the 
quinoid form that absorbs visible light and is 
fluoresce and the lactone form that is colorless and 
non-fluorescent.11  The absorption and fluorescent 
spectral data indicate that UTX-12 exist mainly as 
the lactone form in aqueous solution and that the 
fluorescence of UTX-12 is also quenched by the 
nitro group, a well known quencher of fluorophores. 
5-7 
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2.3. Nitro Reduction of UTX-12 Catalyzed by 
Nitroreductase 
To test the selective deprotection of UTX-12 
via nitro reduction, enzymatic reduction of the 
p-nitrobenzyl moiety was carried out using 
nitroreductase from Escherichia coli (NTR), an 
example of an oxygen-insensitive nitroreductase.12  
When the absorption spectrum and fluorescent 
spectrum of UTX-12 were measured in the NTR, a 
time dependent absorption and fluorescence increase 
originating from SNARF was observed [Figure 3 a) 
and b)]. The conversion yield (95%) from UTX-12 to 
SNARF and the maximal fluorescence change (40 
times) after 6 h treatment were determined by the 
absorption spectrum and fluorescence spectrum, 
respectively.  In contrast, no SNARF fluorescent 
increase was observed in the absence of NTR [Figure 
3 c)].  All of these results indicate that the reduction 
of the nitro substituent of the p-nitro benzyl moiety 
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Figure 3. a-b) Real time spectral change of 
NTR-catalyzed nitro reduction. a) Absorption spectral 
change. b) Fluorescence spectral change. c) Time 
profile of the relative emission intensity. (black circle: 
UTX-12 with NTR, asterisk with circle: UTX-12 
without NTR)  d) The fluorescence spectra of UTX-12 
in the presence (black) or absence (red) of NTR in pH 
5.0 (dot line), pH 7.0 (solid line) and pH 9.0 (dashed 
line), respectively. Inset: Photograph of the 
ratiometric fluorescent response in different pH 
conditions with or without NTR. 
triggered the release SNARF from UTX-12. To 
demonstrate the property of pH response of UTX-12 
after biological reduction of the nitro substituent, the 
UTX-12 solution prepared with or without NTR in 
different pH conditions (pH 5.0, pH 7.0, pH 9.0) 
were observed by using a transilluminator and the 
fluorescent spectrometer.  The dependence of 
fluorescent enhancement by nitro reduction and 
fluorescent color change on the pH was confirmed 
[Figure 3 d)].  Based on these data, UTX-12 was 
demonstrated to function as a fluorescent pH probe 
mediated by nitro reduction. 
 
2.4. Biological Reduction of UTX-12 under 
Different Oxygen Concentrations 
To further evaluate the potential of the 
UTX-12 as a hypoxia-selective pH probe, we used 
fluorescence to monitor its biological reduction in 
different oxygen concentrations.  Preparations of 
liver microsomes of chick embryo were used as a 
metabol ic  enzyme cocktai l .  This  includes 
cytochrome P450 reductase, an electron-donating 
protein that catalyzes the one-electron reduction of 
nitro derivatives to nitro anion radicals.13  UTX-12 
was incubated with the microsomes in different 
oxygen concentrations, including hypoxic (without 
oxygen), aerobic (20% v/v) and oxic conditions 
(95% v/v), respectively. The time course of 
fluorescent spectral change under hypoxic conditions 
is shown in Figure 4a). Intense fluorescence emission 
originating from SNARF and its time dependent 
increase (6-fold after 20 h incubation) were observed 
[inset of Figure 4a)]. In contrast, under both aerobic 
and oxic conditions after 20 h incubation, the extent 
of enhanced fluorescence intensity diminished 
significantly as a result of the competitive  
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Figure 4. a) The spectral change of the UTX-12 
incubated with liver microsomes of chick embryo 
under hypoxic condition at different incubation times 
(0, 2.5, 5, 10 and 20 h).  Inset: Time profile of the 
relative emission intensity (lem= 627 nm) caused by 
incubation under hypoxic conditions.  b) 
Fluorescence spectra of UTX-12 resulting from 
incubation under different oxygen concentration. 
(solid line: UTX-12 was incubated with liver 
microsomes for 20 h under hypoxic (red), aerobic 
(green) and oxic (blue) conditions, dashed line (black): 
UTX-12 was incubated with liver microsomes for 0 h, 
dotted line (black):UTX-12 in 0.1 M phosphate buffer 
(pH 7.4) without liver microsomes.  Inset: The 
relative emission intensity of UTX-12 (lem= 627 nm) 
incubated in the different oxygen concentration. 
 
scavenging by molecular oxygen [Figure 4b) and 
inset].  The hypoxic-aerobic or oxic fluorescence 
differential became almost 5-6-fold after 20 h 
incubation.  All of these results demonstrated that 
UTX-12 was reduced and SNARF was produced 
under hypoxic conditions, selectively. 
 
2.5. Fluorescent Imaging of Hypoxic Cell by Using 
UTX-12 
To further assess the potential applications of 
UTX-12, fluorescent imaging inside the hypoxic cell 
using UTX-12 was examined.  V79 cells (Chinese 
hamster lung) were incubated with UTX-12 under 
hypoxic or aerobic conditions, respectively.  After 
exchanging medium, confocal laser scan microscopy 
(CLSM) was performed.  As shown Figure 5b), 
strong fluorescence in the cytosol of V79 cells which 
were incubated under hypoxic conditions was 
observed.  In contrast, negligible fluorescence was 
observed in the cells treated under aerobic conditions 
(Figure 5d). Figure 5e) shows the time-course of 
fluorescence intensity of UTX-12 incubated under 
different conditions.  The hypoxic-aerobic 
fluorescent differential increased 4-fold after 
incubation for 6 h.  These results indicate that 
UTX-12 responds to the oxygen concentration and 
that UTX-12 has a potential to use as a fluorescent 
pH probe in cell.  
 
3. Conclusion 
We have demonstrated that UTX-12 can be 
selectively activated by reductive enzymes under the 
conditions of tumor hypoxia.  This activation in 
turn triggers to release SNARF inside tumor cells 
where it should monitor the pHi selectively with 
reduced background signal.  Although SNARF 
derivatives have previously been used to monitor 
intra- or extracellular compartments for different 
purposes, we note that UTX-12 is the first example 
of selective translocation of SNARF as a fluorescent 
pH probe into tumor cells. On these points, we 
believe that UTX-12 should be a promising 
candidate for further evaluation as a fluorescent pH 
probe for tumor hypoxia in vivo.  In addition to 
monitoring the oxygen environment, potential 
applications include following the effects of drug 
treatment through pHi measurement. 
 
4. Experimental 
4.1. Spectroscopic assessment 
4.1.1. Measurement of extinction coefficients 
The extinction coefficient (e) of UTX-12 was 
calculated according to the Lambert-Beer law.  
Absorption spectra of the samples were measured in 
pH 5.0 10 mM acetate, HEPES and Tris buffer.  
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Figure 5. a-d) Fluorescence microphotograph of V79 cells incubated with UTX-12 for 6 h under a,b) hypoxic 
conditions (incubated in 95% N2 and 5% CO2) or c,d) aerobic conditions (incubated under atmosphere gas). a,c) 
Transmission channel. b,d) fluorescence channel. The scale bar (50 mm) are shown in the photograph.  e) The time 
courses of accumulation of fluorescent intensity in V79 cells incubated with UTX-12  under hypoxic (●) or aerobic 
(○) conditions. 
 
4.1.2. Fluorescence spectrophotometry 
Fluorescence spectra of UTX-12 and SNARF 
were measured with excitation at 534 nm in pH 5.0 
or pH 7.0 10 mM acetate, HEPES and Tris buffer at 
20 ± 1 °C.  The slit widths of the excitation and 
emission were set to 10 nm and 10 nm, respectively. 
 
4.1.3. Measurement of fluorescence quantum yield 
The fluorescence quantum yield (Φ) was determined 
by integration of corrected emission spectra, 
compared to a SNARF standard with a known value 
of 0.03 of the same optical density at 534 nm.26 
Under these conditions, quantum yields were 
calculated using eq 1. 
Φsample =Φstandard (∫Fem, sample / ∫Fem, standard)   (1) 
 
4.2. Biological analysis 
4.2.1. Bioreductive activation of nitroaromatic 
residue by nitroreductase 
Nitroreductase from Escherichia coli (NTR) 
was purchased from SIGMA co. ltd.  The 
preincubated solution of UTX-12 (5.0 μM) and 
NADPH (500 μM) in the assay buffer (50 mM 
Tris-HCl buffer (pH 7.0)) at 20 ± 1 °C was mixed 
with NTR (final concentration: 0 or 2.0 U/ml). The 
fluorescence spectrum (excitation wavelength: lex = 
534 nm) and UV-vis spectrum then was monitored 
from 0 to 300 min. The conversion yield from 
UTX-12 to SNARF was calculated by UV-vis 
spectrum (e534nm = 25 750 M-1cm-1 ) 
 
The reaction solution of UTX-12 (50 μM) and 
NADPH (2 mM), which was incubated with or 
without NTR (2.0 U/ml) for 22 h under darkness, 
was adjusted pH 5.0, pH 7.0 and pH 9.0 was 
observed by using UV transilluminator (Vilber 
Lourmat TFX-20.M, lex = 312 nm) and fluorescence 
spectrometer. 
 
4.2.2. Bioreductive activation of UTX-12 by 
microsomes of chick embryo under different 
oxygen concentration 
The liver microsomes were prepared according 
to the method reported previously with a slight 
modification.35 Chick embryo liver microsomes were 
prepared from a pooled set of fourteen liver samples 
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(4.899 g).  After homogenization of the liver 
samples in 3 volume of 50 mM phosphate 0.25 M 
sucrose pH 7.4, microsomes (0.777 g wet weight) 
were isolated by centrifugation at 10 000 g and 105 
000 g, and resuspended in 6.0 ml of 0.1 M phosphate 
buffer pH 7.4. The samples were prepared with 
microsomes (64.8 mg/ml), UTX-12 (50 μM), 
NADPH (2 mM) and MgCl2 (3 mM) in 0.1 M 
phosphate buffer pH 7.4.  To establish hypoxic 
conditions, the suspension was degassed with three 
freeze-pump-thaw cycles under nitrogen gas (without 
oxygen). To generate oxic conditions, the suspension 
was vigorously bubbled for 20 seconds with a gas 
mixture containing 95% oxygen and 5% carbon 
dioxide.  For control, similar compositions as in the 
foregoing samples were prepared without UTX-12 or 
microsomes, respectively.  All these samples were 
incubated at 37 °C. After the appropriate incubation 
time (hypoxic conditions: 0, 2.5, 5, 10, 20 h, the 
others: 20 h), these samples were centrifuged at 105 
000 g and the fluorescent spectra of the supernatants 
were measured.   
 
 
4.2.3. Bioimaging of V79 cells incubated under 
different oxygen conditions by using UTX-12 
V79 cells were cultured in Eagle minimum 
essential medium without phenol red containing 
12.5 % (v/v) fetal bovine serum and kanamycin (60 
mg/l) at 37 °C in 5% CO2.  Cells (5 × 104 cells) in 
late log phase were seeded in a 35-mm glass base 
dish.  After growth in a CO2 incubator for 12 h, the 
culture medium was exchanged to drug containing 
medium (UTX-12 50 μM).  The cells were then 
placed in a hypoxic chamber flushed with 5% CO2 
and 95% N2 at 25°C for 2, 4, 6 h at flow rates of 
1.5-2.0 NL/min for hypoxic conditions. For the 
aerobic conditions they were placed at 25 °C under 
atmosphere gas. After treatment, the culture medium 
was exchanged to fresh medium and observed by 
confocal laser scanning microscopy (CLSM, Nikon 
C1si-Ready). Fluorescence at the emission 
wavelength of 605 nm was measured at room 
temperature by exciting SNARF at 544 nm.  The 
fluorescence intensities of the CLSM images were 
obtained by the averaged value of at least ten 
independent points of the photos. The scanning speed 
and the laser intensity were adjusted to avoid 
photobleaching. 
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